UBM Medica US reported at that Neurology Times, an online community and information resource for neurologists and other healthcare providers features special coverage on multiple sclerosis, devoted to fostering better treatment of patients who have the disorder.
According to a release from the company, MS affects 2.5 million persons worldwide, including more than 400,000 Americans, and is the most common disabling neurologic disease of young adults.
Recent coverage of MS on Neurology Times includes:
-Chronic Cerebrospinal Venous Insufficency Not Cause of Multiple Sclerosis: Hypothesis Rest in Peace: A researcher and regular contributor describes a new study that puts a final nail in the coffin for a questionable hypothesis about causation.
-The Trouble with Tysabri: How to use the medication responsibly and effectively is the subject of this month's blog from Professor of Neurology and Neuroscience Samuel Pleasure, MD, PhD.
-Stroke and other PRES-sing Issues: A Photo Essay: MRIs of progressing relapsing-remitting MS are presented in this instructive slide show.
-5 Things You May Not Know About Multiple Sclerosis: Succinct highlights from new studies may offer you insights about MS you didn't have before.
UBM Medica US, delivers strategic, integrated communications solutions and reach -- online, in print, via custom programs and live events.
UBM plc is a global events-led marketing services and communications company.
Story Source: The above story is based on materials provided by INDIVIDUAL
Note: Materials may be edited for content and length
Click here to read original article
